发布求助
文献互助 智能选刊 最新文献

Best Practice & Research Clinical Gastroenterology最新文献

筛选
英文 中文
Complications and management of interventional endoscopic ultrasound: A critical review 介入性内窥镜超声的并发症和处理：重要综述
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-03-01 DOI: 10.1016/j.bpg.2024.101888
Carlo Fabbri , Davide Scalvini , Giuffrida Paolo , Cecilia Binda , Aurelio Mauro , Chiara Coluccio , Stefano Mazza , Margherita Trebbi , Francesca Torello Viera , Andrea Anderloni
{"title":"Complications and management of interventional endoscopic ultrasound: A critical review","authors":"Carlo Fabbri ,&nbsp;Davide Scalvini ,&nbsp;Giuffrida Paolo ,&nbsp;Cecilia Binda ,&nbsp;Aurelio Mauro ,&nbsp;Chiara Coluccio ,&nbsp;Stefano Mazza ,&nbsp;Margherita Trebbi ,&nbsp;Francesca Torello Viera ,&nbsp;Andrea Anderloni","doi":"10.1016/j.bpg.2024.101888","DOIUrl":"10.1016/j.bpg.2024.101888","url":null,"abstract":"<div><p>In the last decades, Endoscopic ultrasound (EUS) has rapidly grown and evolved from being mainly a diagnostic procedure, to being an interventional and therapeutic tool in several pathological clinical scenarios. With the progressive growth in technical expertise and dedicated devices, interventional endoscopic ultrasound procedures (IEUSP) have shown high rates of technical and clinical success, together with a relatively safe profile. However, the description and the standardization of different and specific types of adverse events (AEs) are still scarce in literature, and, consequently, even less the management of AEs. The aim of this study is to critical review and to describe AEs related to each of the main IEUSP, and to provide an overview on the possible management strategies of endoscopic complications. Future studies and guidelines are surely required to reach a better standardization of different AEs and their best management.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"69 ","pages":"Article 101888"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139668922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention of post-ERCP complications 预防ERCP术后并发症
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-03-01 DOI: 10.1016/j.bpg.2024.101906
Lotfi Triki , Andrea Tringali , Marianna Arvanitakis , Tommaso Schepis
{"title":"Prevention of post-ERCP complications","authors":"Lotfi Triki ,&nbsp;Andrea Tringali ,&nbsp;Marianna Arvanitakis ,&nbsp;Tommaso Schepis","doi":"10.1016/j.bpg.2024.101906","DOIUrl":"10.1016/j.bpg.2024.101906","url":null,"abstract":"<div><p>Endoscopic retrograde cholangiopancreatography (ERCP) is a common endoscopic procedure which plays a key role in the management of diseases of the bile ducts and the pancreas. Despite ERCP being performed routinely since more than 4 decades, it is still related to a considerable rate of complications with post-ERCP pancreatitis being the most frequent one.</p><p>Lately, endoscopic techniques have evolved, and numerous modalities have been developed to prevent or manage ERCP-related complications, especially PEP, such as the use of intra-rectal non-steroidal anti-inflammatory drugs (NSAIDs), insertion of prophylactic stents in the pancreatic duct (PD) or intravenous hyperhydration. Knowledge of the various risk factors and applying validated preventive methods are keys in providing a safe procedure and optimizing overall patient care.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"69 ","pages":"Article 101906"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140322620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic management of surgical complications 手术并发症的内窥镜治疗
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-03-01 DOI: 10.1016/j.bpg.2024.101898
Mayank Goyal , Anmol Bains , Yadwinder Singh , Fnu Deepali , Anmol Singh , Shubham Sood , Navtej S. Buttar
{"title":"Endoscopic management of surgical complications","authors":"Mayank Goyal ,&nbsp;Anmol Bains ,&nbsp;Yadwinder Singh ,&nbsp;Fnu Deepali ,&nbsp;Anmol Singh ,&nbsp;Shubham Sood ,&nbsp;Navtej S. Buttar","doi":"10.1016/j.bpg.2024.101898","DOIUrl":"10.1016/j.bpg.2024.101898","url":null,"abstract":"<div><p>While the endoscopic management of surgical complications like leaks, fistulas, and perforations is rapidly evolving, its core principles revolve around closure, drainage, and containment. Effectively managing these conditions relies on several factors, such as the underlying cause, chronicity of the lesion, tissue viability, co-morbidities, availability of devices, and expertise required to perform the endoscopy. In contrast to acute perforation, fistulas and leaks often demand a multimodal approach requiring more than one session to achieve the required results. Although the ultimate goal is complete resolution, these endoscopic interventions can provide clinical stability, enabling enteral feeding to lead to early hospital discharge or elective surgery. In this discussion, we emphasize the current state of knowledge and the prospective role of endoscopic interventions in managing surgical complications.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"69 ","pages":"Article 101898"},"PeriodicalIF":3.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140055155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of non-curative endoscopic resection of T1 colon cancer T1 结肠癌非根治性内窥镜切除术的处理方法
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101891
Linn Bernklev , Jens Aksel Nilsen , Knut Magne Augestad , Øyvind Holme , Nastazja Dagny Pilonis
{"title":"Management of non-curative endoscopic resection of T1 colon cancer","authors":"Linn Bernklev ,&nbsp;Jens Aksel Nilsen ,&nbsp;Knut Magne Augestad ,&nbsp;Øyvind Holme ,&nbsp;Nastazja Dagny Pilonis","doi":"10.1016/j.bpg.2024.101891","DOIUrl":"10.1016/j.bpg.2024.101891","url":null,"abstract":"<div><p>Endoscopic resection techniques enable en-bloc resection of T1 colon cancers. A complete removal of T1 colon cancer can be considered curative when histologic examination of the specimens shows none of the high-risk factors for lymph nodes metastases. Criteria predicting lymph nodes metastases include deep submucosal invasion, poor differentiation, lymphovascular invasion, and high-grade tumor budding. In these cases, complete (R0), local endoscopic resection is considered sufficient as negligible risk of lymph nodes metastases does not outweigh morbidity and mortality associated with surgical resection. Challenges arise when endoscopic resection is incomplete (RX/R1) or high-risk histological features are present. The risk of lymph node metastasis in T1 CRC ranges from 1% to 36.4%, depending on histologic risk factors. Presence of any risk factor labels the patient “high risk,” warranting oncologic surgery with mesocolic lymphadenectomy. However, even if 70%–80% of T1-CRC patients are classified as high-risk, more than 90% are without lymph node involvement after oncological surgery. Surgical overtreatment in T1 CRC is a challenge, requiring a balance between oncologic safety and minimizing morbidity/mortality. This narrative review explores the landscape of managing non-curative T1 colon cancer, focusing on the choice between advanced endoscopic resection techniques and surgical interventions. We discuss surveillance strategies and shared decision-making, emphasizing the importance of a multidisciplinary approach.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"68 ","pages":"Article 101891"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1521691824000106/pdfft?md5=c94d8b61155331408a5a5f9e20d2c4bd&pid=1-s2.0-S1521691824000106-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139954125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copyright Information 版权信息
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/S1521-6918(24)00024-6
{"title":"Copyright Information","authors":"","doi":"10.1016/S1521-6918(24)00024-6","DOIUrl":"https://doi.org/10.1016/S1521-6918(24)00024-6","url":null,"abstract":"","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"68 ","pages":"Article 101905"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140191958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of high risk T1 gastric adenocarcinoma following endoscopic resection 内镜切除术后高风险 T1 胃腺癌的管理
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101887
Jéssica Chaves , Diogo Libânio , Pedro Pimentel-Nunes
{"title":"Management of high risk T1 gastric adenocarcinoma following endoscopic resection","authors":"Jéssica Chaves ,&nbsp;Diogo Libânio ,&nbsp;Pedro Pimentel-Nunes","doi":"10.1016/j.bpg.2024.101887","DOIUrl":"10.1016/j.bpg.2024.101887","url":null,"abstract":"<div><p><span>Endoscopic submucosal dissection<span> has revolutionized the treatment of early gastric cancer. However, cases that do not meet the curability criteria have a higher risk of </span></span>lymph node metastasis and salvage surgery is still considered the next treatment approach to increase the chance of cure. Nevertheless, not all high-risk resections entail the same level of risk, emphasizing the utmost importance of individualized stratification for further treatment. In this review, we aim to examine the current evidence concerning the management following a high-risk non-curative resection, highlighting the existing approaches, while also presenting upcoming strategies that attempt to improve patient outcomes, minimize adverse events, and provide a tailored management.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"68 ","pages":"Article 101887"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139644660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of high risk T1 esophageal adenocarcinoma following endoscopic resection 内镜切除术后高风险 T1 食管腺癌的处理方法
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101882
Philippe Leclercq , Raf Bisschops , Jacques J.G.H.M. Bergman , Roos E. Pouw
{"title":"Management of high risk T1 esophageal adenocarcinoma following endoscopic resection","authors":"Philippe Leclercq ,&nbsp;Raf Bisschops ,&nbsp;Jacques J.G.H.M. Bergman ,&nbsp;Roos E. Pouw","doi":"10.1016/j.bpg.2024.101882","DOIUrl":"10.1016/j.bpg.2024.101882","url":null,"abstract":"<div><p>High-risk T1 esophageal adenocarcinoma (HR-T1 EAC) is defined as T1 cancer, with one or more of the following histological criteria: submucosal invasion, poorly or undifferentiated cancer, and/or presence of lympho-vascular invasion. Esophagectomy has long been the only available treatment for these HR-T1 EACs and was considered necessary because of a presumed high risk of lymph node metastases up to 46%. However, endoscopic submucosal disscection have made it possible to radically remove HR-T1 EAC, irrespective of size, while leaving the esophageal anatomy intact. Parallel to this development, new publications demonstrated that the risk of lymph node metastases for HR-T1 EAC may be even &lt;24%. Therefore, indications for endoscopic treatment of HR-T1 EAC are being reconsidered and current research aims at finding the optimal management strategy for this indication, where watchful waiting may proof to be an acceptable strategy in selected patients. In this review, we will discuss the latest developments in this field.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"68 ","pages":"Article 101882"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139669059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management after non-curative endoscopic resection of T1 rectal cancer T1 直肠癌非根治性内窥镜切除术后的处理方法
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101895
Hao Dang, Daan A. Verhoeven, Jurjen J. Boonstra, Monique E. van Leerdam
{"title":"Management after non-curative endoscopic resection of T1 rectal cancer","authors":"Hao Dang,&nbsp;Daan A. Verhoeven,&nbsp;Jurjen J. Boonstra,&nbsp;Monique E. van Leerdam","doi":"10.1016/j.bpg.2024.101895","DOIUrl":"10.1016/j.bpg.2024.101895","url":null,"abstract":"<div><p>Since the introduction of population-based screening, increasing numbers of T1 rectal cancers are detected and removed by local endoscopic resection. Patients can be cured with endoscopic resection alone, but there is a possibility of residual tumor cells remaining after the initial resection. These can be located intraluminally at the resection site or extraluminally in the form of (lymph node) metastases. To decrease the risk of residual cells progressing towards more advanced disease, additional treatment is usually needed. However, with the currently available risk stratification models, it remains challenging to determine who should and should not be further treated after non-curative endoscopic resection. In this review, the different management strategies for patients with non-curatively treated T1 rectal cancers are discussed, along with the available evidence for each strategy and relevant considerations for clinical decision making. Furthermore, we provide practical guidance on the management and surveillance following non-curative endoscopic resection of T1 rectal cancer.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"68 ","pages":"Article 101895"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1521691824000143/pdfft?md5=db68317b9ccbdd8d245b0694536ea500&pid=1-s2.0-S1521691824000143-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139954127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curative criteria for endoscopic treatment of oesophageal squamous cell cancer 食道鳞状细胞癌内镜治疗的治愈标准
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101894
Toshiro Iizuka
{"title":"Curative criteria for endoscopic treatment of oesophageal squamous cell cancer","authors":"Toshiro Iizuka","doi":"10.1016/j.bpg.2024.101894","DOIUrl":"10.1016/j.bpg.2024.101894","url":null,"abstract":"<div><p>Endoscopic treatment of early oesophageal squamous cell carcinoma is widely accepted. ESD (Endoscopic Submucosal Dissection), which allows en bloc resection regardless of size, provides resected specimens that facilitate histological evaluation of curability. In the histological investigation, the determination of tumor depth, lymphovascular involvement, and lateral and vertical margins play a great role in the assessment of curability. The diagnosis of lymphovascular invasion, in particular, is enhanced by the addition of immunostaining. The long-term outcome of ESD is comparable to that of oesophagectomy, and ESD may be the first-line treatment for early-stage oesophageal cancer due to its fewer complications. Surveillance after curative resection is also imperative because oesophageal cancer is often characterized by the concept of field cancerization, which results in metachronous multiple primary lesions.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"68 ","pages":"Article 101894"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139925113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal treatment with endoscopic ablation and systemic therapy for cholangiocarcinoma 胆管癌的内镜消融和系统治疗多模式疗法
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-02-01 DOI: 10.1016/j.bpg.2024.101893
Zaheer Nabi , Michał Żorniak , D Nageshwar Reddy
{"title":"Multimodal treatment with endoscopic ablation and systemic therapy for cholangiocarcinoma","authors":"Zaheer Nabi ,&nbsp;Michał Żorniak ,&nbsp;D Nageshwar Reddy","doi":"10.1016/j.bpg.2024.101893","DOIUrl":"10.1016/j.bpg.2024.101893","url":null,"abstract":"<div><p>Cholangiocarcinoma (CCA) are primary malignancies of biliary system and usually unresectable at the time of diagnosis. As a consequence, majority of these cases are candidates for palliative care. With the advances in chemotherapeutic agents and multidisciplinary care, the survival rate has improved in cases with inoperable malignant biliary obstruction. As a consequence, there is a need to provide effective and durable palliative care in these patients. The main role of endoscopic palliation in the vast majority of CCA includes biliary stenting for obstructive jaundice. Recent advances in the endoscopic palliation and multimodal approach appear promising in imparting durable relief of symptoms. Use of radiofrequency ablation, photodynamic therapy and intraluminal brachytherapy has been shown to improve the survival rates as well as the patency of biliary stents. Infact, intraductal ablation may act synergistically with chemotherapy by modulating tumour signalling pathways and immune microenvironment.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"68 ","pages":"Article 101893"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139928192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信